Cuevas, Fahiza .

HRN: 28-68-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2026
CEFTRIAXONE 1G (VIAL)
03/11/2026
03/18/2026
IV DRIP IN 1 HOUR
1.7g
Q24h
PCAP C
Checking Initial Appropriateness 
03/11/2026
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
03/11/2026
03/14/2026
PO
2ml
OD
PCAP C
Remove - Pending Acceptance
03/15/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/15/2026
03/21/2026
IV
170mg
Q8H
Sepsis
Checking Initial Appropriateness 
03/25/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/25/2026
04/01/2026
IV
1.7g
Q8
PCAP-C
Remove - Pending Acceptance
03/25/2026
CLINDAMYCIN 150MG (CAP)
03/25/2026
04/12/2026
PO
1 Cap / 150mg
Q 8 Hours
PCAP-C
Remove - Pending Acceptance
03/27/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/27/2026
04/03/2026
IV
1.7g
Q8h
Pcap C
Remove - Pending Acceptance
03/29/2026
COTRIMOXAZOLE 960MG (TAB)
03/29/2026
04/05/2026
ORAL
Half Tablet (480mg)
OD
PSNB
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: